Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis

Phillip H. Kuo, Emanuel Kanal, Ali K. Abu‐Alfa, Shawn E. Cowper

Radiology

January 10, 2007

10.1148/radiol.2423061640

Cited by 634

Abstract

Related Papers

Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Thomas Grobner|Nephrology Dialysis Transplantation|2006|1.8k

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

Shawn E. Cowper, H Robin, Steven M. Steinberg et al.|The Lancet|2000|878

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

Whitney A. High, Reed Ayers, John P. Chandler et al.|Journal of the American Academy of Dermatology|2006|542

Nephrogenic Fibrosing Dermopathy

Shawn E. Cowper, Lyndon D. Su, Jag Bhawan et al.|American Journal of Dermatopathology|2001|479

Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and Therapy

Peter Stenvinkel, Anders Alvestrand|Seminars in Dialysis|2002|416